You are here: Industry Insights > EU

News List

Seven therapies backed for EU approval pharmatimes
December 19, 2017
Seven therapies have been put forward for approval in the European Union, bringing closer new options for a range of conditions including Crohn’s disease, diabetes and cancer.
CHMP backs 13 treatments for EU approval pharmatimes
September 19, 2017
Thirteen new therapies - including two biosimilars - have been backed for approval in Europe.
Scottish firm gets EU funding for ‘off the shelf’ cancer cell therapy pharmaphorum
August 04, 2017
Scottish biotech TC BioPharm (TCB) has won European Union funding to develop a new “off-the-shelf” cell therapy for several types of solid tumour cancers.
UK trails behind EU in cancer diagnosis & treatment europeanpharmaceuticalreview
July 19, 2017
A new report shows that the UK is trailing behind the rest of Europe in the diagnosis and treatment of cancer.
EC approves Pfizer's Xeljanz to treat rheumatoid arthritis in EU pharmaceutical-technology
March 29, 2017
The European Commission (EC) has approved Pfizer's Xeljanz (tofacitinib citrate) oral tablets to treat moderate-to-severe active rheumatoid arthritis (RA) in adult patients in the European Union (EU).
Six new medicines backed for EU approval pharmatimes
March 28, 2017
Six new medicines, including three orphan drugs for rare diseases, have been backed for European Union approval by the European Medicines Agency’s Committee for Medicinal Products ...